Seastar Medical

This study monitors the safety of QUELIMMUNE, a device already approved for emergency use in critically ill children with acute kidney injury caused by sepsis. Researchers will track 50 patients to see how many develop new bloodstream infections within 28 days. The goal is to ens…

This study tests a device called the Selective Cytopheretic Device (SCD) in 339 ICU patients with severe acute kidney injury who are already on continuous kidney replacement therapy. The device filters blood to reduce inflammation, and researchers want to see if it improves survi…

This study tests a device that filters out overactive immune cells from the blood to reduce inflammation in patients with severe heart failure and worsening kidney function. Twenty ICU patients will receive 4-hour treatments daily for up to 6 days. The goal is to see if it safely…